PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-01-17

Date Title Company
17-Jan-2023 Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next-Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality Avectas
17-Jan-2023 CCDC Welcomes New Applications for its FAIRE Grants to Advance Structural Science Cambridge Crystallographic Data Centre (CCDC)
17-Jan-2023 Better health system partnerships can improve equality of access to innovative medicines ABPI
17-Jan-2023 Calibre Scientific Acquires Glass Chemicals, a Comprehensive Provider of Laboratory Consumables, Equipment and Services in Spain Calibre Scientific
17-Jan-2023 Ovarian cancer: Innovative research approach identifies target proteins for potential anti-tumor drug rhenium tricarbonyl (TRIP). IMC Krems – University of Applied Sciences
17-Jan-2023 Leading global pharma firms exit UK drug pricing agreement ABPI
17-Jan-2023 Approval of GMP Registration by MHRA Celadon Pharmaceuticals Plc
17-Jan-2023 Full Year Trading update Spectral MD Holdings, Ltd
17-Jan-2023 Poolbeg announces strategic expansion of POLB 001 into oncology Poolbeg Pharma Plc
17-Jan-2023 Remote Patient Monitoring Users to Reach 115 Million Globally by 2027; Driven by Healthcare System Pressures Juniper Research
17-Jan-2023 Eckert & Ziegler Exceeds Forecast for the 2022 Financial Year According to Preliminary Figures Eckert & Ziegler Strahlen- und Medizintechnik AG
17-Jan-2023 SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial SolasCure
17-Jan-2023 Enalees appoints Eric Germain as managing director Andrew Lloyd Associates
17-Jan-2023 InnoScot Health hails ‘fantastic’ funding for MHRA projects InnoScot Health
17-Jan-2023 Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next-Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality Avectas
17-Jan-2023 ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002 ImmunOs Therapeutics
17-Jan-2023 Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer Pan Cancer T
17-Jan-2023 Industry-First Cancer Screening Technology Boosted by Biomedical Grant Funding Medicines Discovery Catapult
17-Jan-2023 GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma GPCR Therapeutics
17-Jan-2023 Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project Andrew Lloyd Associates